Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

ABBOTT LABORATORIES Aktie

 >ABT Aktienkurs 
83.16 EUR    -0.4%    (TradegateBSX)
Ask: 84.4 EUR / 60 Stück
Bid: 83.16 EUR / 61 Stück
Tagesumsatz: 1735 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ABT Aktie über LYNX handeln
>ABT Performance
1 Woche: +0,6%
1 Monat: +10,8%
3 Monate: -6,8%
6 Monate: -21,5%
1 Jahr: -27,4%
laufendes Jahr: -21,4%
>ABBOTT LABORATORIES Aktie
Name:  ABBOTT LABORATORIES
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US0028241000 / 850103
Symbol/ Ticker:  ABL (Frankfurt) / ABT (NYSE)
Kürzel:  FRA:ABL, ETR:ABL, ABL:GR, NYSE:ABT
Index:  S&P500
Webseite:  https://www.abbott.com/
Profil:  Abbott Laboratories is a diversified healthcare company that discovers, develops, manufactures, and sells a comprehensive range of medical products and pharmaceuticals globally. The company operates through four primary segments: Established Pharmace..
>Volltext..
Marktkapitalisierung:  145279.84 Mio. EUR
Unternehmenswert:  168978.83 Mio. EUR
Umsatz:  39460.21 Mio. EUR
EBITDA:  9778.94 Mio. EUR
Nettogewinn:  5487.92 Mio. EUR
Gewinn je Aktie:  3.15 EUR
Schulden:  29766.96 Mio. EUR
Liquide Mittel:  5947.8 Mio. EUR
Operativer Cashflow:  8274.28 Mio. EUR
Bargeldquote:  0.4
Umsatzwachstum:  -0.19%
Gewinnwachstum:  -56.24%
Dividende je Aktie:  2.09 EUR
Dividendenrendite:  2.56%
Dividendenschätzung:  2.64%
Div. Historie:  15.04.26 - 0.53442895€
15.01.26 - 0.542178€
>weitere anzeigen...
Insiderhandel:  1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 151.812 Euro.
Suchwörter:  ABBOTT LABORATORIES, ABBOTT LABS, ABBOTT LAB, (ABT), ABT
Letzte Datenerhebung:  05.07.26
>ABT Kennzahlen
Aktien/ Unternehmen:
Aktien: 1741.81 Mio. St.
Frei handelbar: 99.32%
Rückkaufquote: 0.34%
Mitarbeiter: 115000
Umsatz/Mitarb.: 0.34 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 22.33%
Bewertung:
KGV: 26.75
KGV lG: 17.36
KUV: 3.68
KBV: 3.21
PEG-Ratio: -
EV/EBITDA: 17.28
Rentabilität:
Bruttomarge: 52.84%
Gewinnmarge: 13.91%
Operative Marge: 17.77%
Managementeffizenz:
Gesamtkaprendite: 6.54%
Eigenkaprendite: 12.45%
 >ABT Anleihen 
>ABT Peer Group
 
01.07.26 - 23:12
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? (Fool)
 
Abbott's broad healthcare reach and Intuitive's robotic surgery focus present distinct financial strengths and risks for investors weighing portfolio strategy....
01.07.26 - 19:12
Baird stuft Abbott mit "Outperform" ein: Produktpipeline als Wachstumstreiber (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
01.07.26 - 14:06
Here Are Wednesday′s Best Wall Street Analyst Research Calls: Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesforce, ServiceNow,SpaceX, and More (24/7 Wall St.)
 
Pre-Market Stock Futures: Futures are trading lower as we get ready to start the third quarter after a record-setting second quarter that saw the Dow Jones Industrial Average close at 52,317, up 0.26% to finish the venerable index's best first half since 2021, while the Nasdaq finished the session at 26,213, up 1.52% for the ... Here Are Wednesday's Best Wall Street Analyst Research Calls: Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesforce, ServiceNow,SpaceX, and More...
30.06.26 - 03:36
AnteoTech Launches Anteo C Performance-Enhancing Primer Additive for Lithium-Ion Batteries (Small Caps)
 
AnteoTech launches Anteo C primer additive for Li-ion batteries, expanding ABT with pilot-scale trials in Korea and India; PFAS-free, water-based, ADO upside....
30.06.26 - 01:45
Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
 
The latest trading day saw Abbott (ABT) settling at $92.71, representing a -1.5% change from its previous close....
29.06.26 - 16:45
How Abbott′s Largest Segment Is Preparing for the Next Growth Phase (Zacks)
 
ABT's Medical Devices unit builds on strong growth with new diabetes, heart rhythm and electrophysiology advances ahead of Q2 2026....
28.06.26 - 16:36
In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000 (Fool)
 
Abbott Labs could rally in a downturn and has a long-term growth catalyst to boot....
25.06.26 - 20:24
Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy (24/7 Wall St.)
 
Abbott Laboratories (NYSE:ABT) at $90.53 is a Buy. The healthcare giant has been swept up in a sector-wide rotation out of defensive names, even as its diabetes franchise compounds and its medical devices unit posts double-digit growth. Abbott spans medical devices, diagnostics, established pharmaceuticals, and nutrition, with Robert B. Ford as CEO. FreeStyle Libre, the ... Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy...
24.06.26 - 19:42
Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy (24/7 Wall St.)
 
Abbott Laboratories (NYSE:ABT) is a stock with characteristics suited to multi-decade ownership, because its four-segment healthcare engine, 54 consecutive years of dividend increases, and recession-resistant end markets give a retirement-focused portfolio something rare: cash compounding that does not require monitoring. Pillar One: Durability Built Into the Business Model Abbott's revenue flows from four distinct segments ... Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy...
24.06.26 - 15:12
ALZpath Inks Licensing Deal With Abbott To Expand Blood-Based Alzheimer′s Disease Testing (AFX)
 
NORTH CHICAGO (dpa-AFX) - Wednesday, ALZpath Inc. announced a licensing agreement with Abbott Laboratories (ABT) to incorporate the company's proprietary phosphorylated Tau 217 antibody into the d......
22.06.26 - 16:45
How to Approach Abbott Stock Following Its Sharp YTD Decline? (Zacks)
 
ABT falls 29.4% YTD as respiratory testing weakness, China uncertainty and acquisition dilution pressure results and outlook....
20.06.26 - 21:36
Should You Buy Abbott Labs Stock Hand Over Fist Before July 16? (Fool)
 
July earnings matter, but long-term growth matters more....
16.06.26 - 17:30
Abbott′s CGM Growth Story Stays Intact Despite Q1 Moderation (Zacks)
 
ABT's CGM sales growth slows in Q1, but management sees a return to double-digit gains as Libre expands with new products and AI tools....
13.06.26 - 01:45
Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors (Zacks)
 
Abbott (ABT) closed the most recent trading day at $88.18, moving 1.64% from the previous trading session....
12.06.26 - 22:09
Abbott Laboratories declares $0.63 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.06.26 - 20:33
Abbott declares 410th consecutive quarterly dividend (PR Newswire)
 
ABBOTT PARK, Ill., June 12, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share. This marks the 410th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 17, 2026,......
11.06.26 - 01:45
Abbott (ABT) Dips More Than Broader Market: What You Should Know (Zacks)
 
In the most recent trading session, Abbott (ABT) closed at $89.17, indicating a -2.28% shift from the previous trading day....
10.06.26 - 16:45
Mounting Evidence Backs Abbott′s Cancer Diagnostics Growth Story (Zacks)
 
ABT's Exact Sciences acquisition expands its cancer diagnostics portfolio as new data and screening guidelines strengthen growth prospects....
09.06.26 - 23:48
New Investors: 3 Rock-Solid Stocks to Build Your Portfolio Around (Fool)
 
Visa, Home Depot, and Abbott Laboratories are blue chip stocks that can provide your portfolio with a good mix of safety, stability, and dividend income over the long term....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Um einen Graben zu füllen, muß ein Hügel abgetragen werden. - Sprichwort Armenien
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!